Brief: HCW Biologics Enters Crada With National Cancer Institute
Dec 8 (Reuters) - HCW Biologics Inc HCWB.O :
* HCW BIOLOGICS ENTERS CRADA WITH NATIONAL CANCER INSTITUTE
* HCW BIOLOGICS-UNDER CRADA, NCI,CO TO PERFORM PHASE 1B/2
CLINICAL
STUDY TO EVALUATE SAFETY, TOLERABILITY OF, HCW9218
Source text for Eikon: ID:nGNXblBpHQ
Further company coverage: HCWB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hcw Biologics
See all newsBrief: HCW Biologics Proposed Resale Of Up To 5.69 Million Shares Of Common Stock
Brief: HCW Biologics To Regain Full Rights For Two Commercial-Ready Reagents From Wugen
Brief: HCW Biologics Prices Private Placement Of 2.8 Mln Units At $1.405 Per Unit
NASDAQ RESUMED AT 09:59 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:54 AM